Nanotechnology and other small scale injectable machines with multistage external magnetic and electrostatic actuation

• US 9,743,942 B2
• Filed: 03/17/2014
• Issued: 08/29/2017
• Est. Priority Date: 03/15/2013
• Status: Active Grant

• Current Assignee: Christopher V. Beckman
• Original Assignee: Christopher V. Beckman
• Inventors: Beckman, Christopher V.
• Primary Examiner(s): Desanto, Matthew F
• Application Number:
  US14/217,448
• Publication Number:
  US 20140343488A1
• Time in Patent Office: 1,261 Days
• CPC Class Codes: A61B 17/22 Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for dilators A61M29/00
• CPC Class Codes: A61B 17/22012 in direct contact with, or very close to, the obstruction or concrement for removing obstructions in blood vessels by laser A61B18/245
• CPC Class Codes: A61B 2017/00017 Electrical control of surgical instruments
• CPC Class Codes: A61B 2017/00199 with a console, e.g. a control panel with a display
• CPC Class Codes: A61B 2017/00345 Micromachines, nanomachines, microsystems
• CPC Class Codes: A61B 2017/00411 actuated by application of energy from an energy source outside the body
• CPC Class Codes: A61B 2017/00876 magnetic
• CPC Class Codes: A61B 2017/22001 Angioplasty, e.g. PCTA
• CPC Class Codes: A61B 2017/22082 after introduction of a substance
• CPC Class Codes: A61B 34/70 Manipulators specially adapted for use in surgery
• CPC Class Codes: A61B 34/73 Manipulators for magnetic surgery
• CPC Class Codes: A61M 5/172 electrical or electronic A61M5/16804, A61M5/16831 take precedence

Abstract

New nanotechnology and other small-scale devices for performing intravenous medical procedures are provided. In some aspect of the invention, a group of encapsulated injectable machines is delivered intravenously into a bloodstream via a syringe. A treatment area within a patient'"'"'s body is specified and targeted for action by an external control system, which also monitors blood flow and other environmental. Externally applied magnetic and/or electrostatic signaling and direction devices controlled by the control system then trigger the release of encapsulation layers surrounding the injectable machines upon reaching the treatment area. The externally applied magnetic signaling and direction devices then drive the machines into treatment targets within the treatment area, exploiting an overall charge and polarity of the machines distinct from their condition during encapsulation. Pulsed magnetic fields then cause polarized moving parts within the machines to move counter to one another, with opposing angled edges breaking up the treatment target. In some embodiments, the machines may also or alternatively deliver a magnetically- or electrostatically-released medication or device to the treatment target. In still other embodiments, a local control unit within the devices may direct additional, more sophisticated actions, which actions may be directed or triggered by external signaling from the externally-applied magnetic signaling and direction devices, or other aspects of the external control system.

Claims

1. An assembly comprising:

a control system configured to produce a pulsed magnetic or electrostatic field;

an injectable machine, comprising;

a body comprising a charge or dipole configured to magnetically- or electrostatically-direct the position of said injectable machine;

a sub-component device comprising part of said injectable machine, wherein said sub-component device comprises an actuator means for triggering the application of a medicament of said injectable machine by said pulsed magnetic or electrostatic field.

2. The assembly of claim 1, wherein said injectable machine is configured for wireless communications with said control system and wherein said control system is capable of directing activities of said injectable machine.

3. The assembly of claim 2, wherein said control system controls said injectable machine with an external electrostatic and/or magnetic field generating device.

4. The assembly of claim 1, wherein said injectable machine is configured to be delivered by hypodermic needle.

5. The assembly of claim 1, wherein said injectable machine is delivered in a cushioning protective fluid.

6. The assembly of claim 1, wherein said body encompasses or surrounds at least some components of said injectable machine and wherein said body is configured to be released by remotely-issued signaling or by at least one command by a control system.

7. The assembly of claim 1, comprising a control-system-detectable tag incorporated within said injectable machine, and configured for uniquely identifying and locating said injectable tag within a treatment area.

8. The assembly of claim 1, comprising a control-system-detectable tag incorporated within said injectable machine, and configured for uniquely identifying and locating said injectable machine within a treatment area.

9. An assembly comprising:

a control system configured to produce a pulsed magnetic or electrostatic field;

an injectable machine, comprising;

a body comprising a charge or dipole configured to magnetically- or electrostatically-direct the position of said injectable machine;

a sub-component device comprising part of said injectable machine, wherein said sub-component device comprises an actuator means for creating and powering rotary action of said injectable machine by said pulsed magnetic or electrostatic field.

10. The assembly of claim 9, wherein said injectable machine is configured for wireless communications with said control system and wherein said control system is capable of directing activities of said injectable machine.

11. The assembly of claim 10, wherein said control system controls said injectable machine with an external electrostatic and/or magnetic field generating device.

12. The assembly of claim 9, wherein said injectable machine is configured to be delivered by hypodermic needle.

13. The assembly of claim 9, wherein said injectable machine is delivered in a cushioning protective fluid.

14. The assembly of claim 9, wherein said body encompasses or surrounds at least some components of said injectable machine and wherein said body is configured to be released by remotely-issued signaling or by at least one command by a control system.

15. The assembly of claim 9, comprising a control-system-detectable tag incorporated within said injectable machine, and configured for uniquely identifying and locating said injectable tag within a treatment area.

16. The assembly of claim 9, comprising a control-system-detectable tag incorporated within said injectable machine, and configured for uniquely identifying and locating said injectable machine within a treatment area.